Simran
Simran is pursuing a combined MD/PhD in the Harvard-MIT MD program and Immunology PhD program. Previously, she was a research technician at Fred Hutch, where she helped design novel protein-based cancer therapeutics and a SARS-CoV-2 vaccine.
Dhruv
Dhruv attended UC Berkeley (BA in Molecular & Cellular Biology), and then worked for the World Health Organization. He is now an MD student at the UC San Diego School of Medicine and member of the Global Health Academic Concentration.
Anna
Anna holds a PhD in Slavic Languages and Literature (Harvard), an MA in Slavic Languages and Literature (MA), a BA in History and Philology (Russian State University) and a BA in Fine Arts (Pushkin State Museum Art College).